The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. - Wikidata - awgldk - TriplyDB

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

http://www.wikidata.org/entity/Q31137576

about

New therapeutic strategies for the treatment of male lower urinary tract symptoms Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment Testosterone and benign prostatic hyperplasia Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection Oxidative stress in prostate hyperplasia and carcinogenesis Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.Prostate cancer and inflammation: the evidence.Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment The burden of prostatic calculi is more important than the presence.Testosterone regulates tight junction proteins and influences prostatic autoimmune responses The effectiveness of dried cranberries ( Vaccinium macrocarpon) in men with lower urinary tract symptoms.Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network Benign prostatic hyperplasia: from bench to clinic Dietary, but not supplemental, intakes of carotenoids and vitamin C are associated with decreased odds of lower urinary tract symptoms in men.Anorectal and Pelvic Pain Interleukin-driven insulin-like growth factor promotes prostatic inflammatory hyperplasia Resolution of chronic bacterial-induced prostatic inflammation reverses established fibrosis.Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue.Prostatic inflammation induces urinary frequency in adult mice Nonsteroidal antiinflammatory drug use and lower urinary tract symptoms: results from the Boston area community health survey.Elevated red blood cell distribution width in benign prostatic hyperplasia patients with metabolic syndrome.Potential protective mechanisms of aryl hydrocarbon receptor (AHR) signaling in benign prostatic hyperplasia Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats Acute bacterial inflammation of the mouse prostate.Expansion of prostate epithelial progenitor cells after inflammation of the mouse prostate.Effect of prostatitis on lower urinary tract symptoms: retrospective analysis of prostate biopsy tissue.DNA methylation as a dynamic regulator of development and disease processes: spotlight on the prostate Correlations of Metabolic Components with Prostate Volume in Middle-Aged Men Receiving Health Check-Up Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) Survey.Is high-sensitivity C-reactive protein associated with lower urinary tract symptoms in aging men? Results from the hallym aging study.Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.Does Inflammation Mediate the Obesity and BPH Relationship? An Epidemiologic Analysis of Body Composition and Inflammatory Markers in Blood, Urine, and Prostate Tissue, and the Relationship with Prostate Enlargement and Lower Urinary Tract Symptoms.Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial A Phase II Randomized Trial of Lycopene-Rich Tomato Extract Among Men with High-Grade Prostatic Intraepithelial Neoplasia.Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey.NF-κB and androgen receptor variant expression correlate with human BPH progression

P2860

Q26746138-8C86AC57-7425-473C-96EE-E2E0AF99D008 Q26782663-4B16A71F-17E2-4C11-BE92-5B4E81AAE7B8 Q26785428-EA9BCBCF-E072-4E65-B5A3-F6690C08E5E0 Q26853374-3B5B54F6-794E-460D-A64F-6510D265525A Q26863719-97B9BF5A-D831-4AE1-9E1B-CEEDE5300851 Q27321863-94D2AE30-562B-41E2-AC1C-8C490AEFCD66 Q28079474-DFC00E28-8C78-4DD7-BED1-E2ACFA0E4A73 Q30617117-8241D354-9E9D-4CA7-96CD-08E54690FC4D Q33642321-18C0F702-5180-4E89-AA24-E189928469F9 Q33741548-29E64F26-AB71-4C25-BF56-28B69B4BE0F6 Q33807378-A7E02C2E-1768-465B-8B19-43C8BC023DED Q33897303-76467848-7783-4268-8623-B1344E7BA1F3 Q33962057-57C8D6F2-39AC-4B99-B1BD-D44BFD9FA3C2 Q34023693-ED4C7C55-EDFB-44B5-AB1A-C0D6039F48A6 Q34163024-9412E8F5-22B2-4F84-9D0B-B08ACB6BDCCC Q34216723-671415F8-75FA-43B7-8EDB-DE488952FF2F Q34493142-A8C6A5DD-76C7-4E30-90C7-E21961A1A0D8 Q34542163-4642B342-690D-4E63-8E55-1E25BCE913B9 Q34573875-093B2B06-1D12-464D-BFB3-287C44683761 Q34641886-C83E3A6E-0294-4D08-A7E5-26E53422C747 Q34978719-2F83887D-DE99-44B7-BFA5-E82CD2F67421 Q35043971-AF09CE0B-6426-4E3C-B934-7D6C67852732 Q35062696-1F774175-9543-4F8E-B95F-BFEA6E2B308F Q35173811-3A2E592B-A674-4A09-8735-7434850D01A8 Q35231612-A04BEE85-CBA4-4A72-9B86-75E180C0ADC6 Q35468651-6BE43024-12B1-48C9-A050-063CBEAC4EB6 Q35661399-B2C87D57-B778-42B3-8434-F787C29F30A6 Q35749659-A6957812-C217-460A-8519-13F55B4A25E5 Q35775413-3244425E-A3EA-4D90-AC74-E110063EB0F3 Q35847749-706ABC68-2DBD-4723-9FD5-5172B8A46522 Q35885619-2A68BC68-6FF9-4D23-AA62-DBFD8E1C6A81 Q35886128-872341E6-632F-45F4-A3EF-E5A796E2B4AA Q35999329-969485EF-DC5C-4E76-ADBA-27AC2013474A Q36003050-A795C3E9-CB96-4618-8BDE-287A6119550B Q36055324-4E02B703-B47F-49CF-A9B0-279058A26853 Q36059979-342432E1-6AAA-40C2-A869-FA2A274874F3 Q36383682-53309C7F-84C9-4114-A945-A761A7545E14 Q36531394-877D4C94-B777-4B2A-9B17-BC01B1595A70 Q36550992-BC6098C8-2BC4-451E-BF34-9C62149017FE Q36606285-1F06B95B-68E9-4BB2-BCD7-3D486E9AA2F2

P2860

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

http://www.wikidata.org/entity/Q31137576

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The relationship between prost ...... ne data from the REDUCE trial.

@ast

The relationship between prost ...... ne data from the REDUCE trial.

@en

type

label

The relationship between prost ...... ne data from the REDUCE trial.

@ast

The relationship between prost ...... ne data from the REDUCE trial.

@en

prefLabel

The relationship between prost ...... ne data from the REDUCE trial.

@ast

The relationship between prost ...... ne data from the REDUCE trial.

@en

P1433

Q31137576-0336841A-A9EC-4B9D-956D-FE71A55755BA

P1476

Q31137576-DA98C286-6A6D-434C-83B3-B6D1C9454774

P2093

Q31137576-0DED9F8D-AC29-45D9-987B-BB2C8A4B0DDD

Q31137576-46D2E635-DDEB-4EA2-8980-5709290C0D58

Q31137576-5C2A1594-2B97-418C-87FE-179E1F3256CA

Q31137576-9B450EFC-9835-4649-9FEB-FD66B3DB8E88

Q31137576-EC04BE8B-35AA-4E32-9BCA-AED17E799182

Q31137576-F1BED272-8F7D-4712-91AE-B71BDE26E84D

P2860

Q31137576-17DC1C27-B928-4125-8B8A-0EBB2064FDD6

Q31137576-18410E64-B3AA-4549-8733-E761CA7F1E5A

Q31137576-4D6E42DA-EC7F-482C-A739-670AAA4E97D2

Q31137576-5ED9FFB6-4351-4C2A-AB0B-361B93A02D8C

Q31137576-8C64968C-986F-4E8F-B670-96BA4CDABBE4

Q31137576-A5BEAA7F-7E90-439F-9615-DD044E372E8A

Q31137576-F43DCD78-66DA-4F1D-9654-34F8AC592DB3

P304

Q31137576-1DE97B47-910B-4C66-A428-B98EFD4AF848

P31

Q31137576-041CFB59-B7D6-4469-B889-BDEC8B0DCF3C

P356

Q31137576-695B7B03-04CB-4FE8-96F5-346A6B88F12E

P407

Q31137576-E78187CE-0902-49F5-B507-FC1D7DEEBBD1

P433

Q31137576-03AC0536-062D-484E-B9AB-878473C89946

P478

Q31137576-A7680A25-8F51-466F-A9D3-0BDDDC942471

P577

Q31137576-E2B2C163-1051-4B0E-80E3-47E011A9206E

P5875

Q31137576-BD142924-A77D-4483-8873-7975241A70A3

P698

Q31137576-46068D61-587B-48BB-8EC0-A966397C0502

P921

Q31137576-3FE211D4-B749-4776-9544-42824D84059D

P932

Q31137576-C93CADC6-0B08-4213-AE8C-11BD827A6731

P356

J.EURURO.2007.11.026

P1433

European Urology

P1476

The relationship between prost ...... ne data from the REDUCE trial.

@en

P2093

Claus G Roehrborn

http://www.w3.org/2001/XMLSchema#string

David G Bostwick

http://www.w3.org/2001/XMLSchema#string

J Curtis Nickel

http://www.w3.org/2001/XMLSchema#string

Matthew C Somerville

http://www.w3.org/2001/XMLSchema#string

Michael P O'Leary

http://www.w3.org/2001/XMLSchema#string

Roger S Rittmaster

http://www.w3.org/2001/XMLSchema#string

P2860

Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia.

Definition of at-risk patients: baseline variables.

Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

Inflammation and chronic prostatic diseases: evidence for a link?

Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.

P304

1379-1384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EURURO.2007.11.026

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5810406

http://www.w3.org/2001/XMLSchema#string

P698

18036719

http://www.w3.org/2001/XMLSchema#string

P921

P932

2643127

http://www.w3.org/2001/XMLSchema#string